Disease | lymphoblastic leukemia |
Comorbidity | C0376545|hematologic malignancies |
Sentences | 1 |
PubMedID- 24513123 | This review analyzes the studies indicating that cd123 is overexpressed in various hematologic malignancies, including a part of acute myeloid and b-lymphoid leukemias, blastic plasmocytoid dendritic neoplasms (bpdcn) and hairy cell leukemia.given the low/absent cd123 expression on normal hematopoietic stem cells, attempts have been made at preclinical first, and then at clinical level to target this receptor. |
Page: 1